focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.02
Bid: 54.90
Ask: 54.94
Change: 0.52 (0.95%)
Spread: 0.04 (0.073%)
Open: 54.52
High: 55.02
Low: 54.20
Prev. Close: 54.50
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

6 Nov 2023 15:57

RNS Number : 5361S
Lloyds Bank PLC
06 November 2023
 

6 November 2023

 

Lloyds Bank plc

Publication of Final Terms

The following Final Terms under the ?60 billion Global Covered Bond Programme of Lloyds Bank plc are available for viewing:

£1,000,000,000 Series 2023-4 Floating Rate Covered Bonds due November 2026

To view the Final Terms, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/5361S_1-2023-11-6.pdf

The Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

 

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

 

+44 (0) 20 7356 1571

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

 

+44 (0) 7788 352 487

Debt Investor Relations:

 

Pascale Dorey

Debt Investor Relations

E-mail: pascale.dorey@lloydsbanking.com

 

+44 (0) 20 7354 7402

Lloyds Bank plc

Registered Office

25 Gresham Street

London EC2V 7HN

Disclaimer - Intended Addressees

Please note that the information contained in this announcement and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and Final Terms are not addressed. Prior to relying on the information contained in this announcement and the Final Terms, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Final Terms.

In particular, this announcement and the Final Terms do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Final Terms are not for distribution in the United States or to U.S. persons (as defined below). The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act) or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTUNVVROOUARAA
Date   Source Headline
4th Aug 20235:19 pmRNSTransaction in Own Shares
3rd Aug 20235:28 pmRNSTransaction in Own Shares
31st Jul 20235:36 pmRNSTransaction in Own Shares
31st Jul 20234:00 pmRNSDirector/PDMR Shareholding
31st Jul 202312:00 pmRNSTotal Voting Rights
27th Jul 202310:00 amRNSDirector Declaration
26th Jul 20235:33 pmRNSTransaction in Own Shares
26th Jul 202312:18 pmRNSPublication of Suppl.Prospcts
26th Jul 202311:57 amRNS2023 Half-Year Results
26th Jul 202311:56 amRNS2023 Half-Year Results
26th Jul 20237:00 amRNS2023 Half-Year Results - Part 2 of 2
26th Jul 20237:00 amRNS2023 Half-Year Results - Part 1 of 2
14th Jul 20235:23 pmRNSTransaction in Own Shares
13th Jul 20235:26 pmRNSTransaction in Own Shares
12th Jul 20235:38 pmRNSTransaction in Own Shares
12th Jul 20234:45 pmRNSDirector/PDMR Shareholding
12th Jul 20237:13 amRNSBOE STRESS TEST PASSED
11th Jul 20235:33 pmRNSTransaction in Own Shares
10th Jul 20235:41 pmRNSTransaction in Own Shares
10th Jul 202310:49 amRNSNotice of Redemption
7th Jul 20235:43 pmRNSTransaction in Own Shares
6th Jul 20235:25 pmRNSTransaction in Own Shares
5th Jul 20235:38 pmRNSTransaction in Own Shares
4th Jul 20235:38 pmRNSTransaction in Own Shares
3rd Jul 202312:00 pmRNSBlock listing Interim Review
30th Jun 20235:49 pmRNSPublication of a Prospectus
30th Jun 20235:28 pmRNSTransaction in Own Shares
30th Jun 20232:36 pmRNSTotal Voting Rights
29th Jun 20235:27 pmRNSTransaction in Own Shares
28th Jun 20235:37 pmRNSTransaction in Own Shares
27th Jun 20235:30 pmRNSTransaction in Own Shares
26th Jun 20236:07 pmRNSTransaction in Own Shares
26th Jun 20234:25 pmRNSTransaction in Own Shares - Replacement
23rd Jun 20235:22 pmRNSTransaction in Own Shares
23rd Jun 20234:32 pmRNSTotal Voting Rights
22nd Jun 20235:53 pmRNSTransaction in Own Shares
22nd Jun 20232:00 pmRNSDirector/PDMR Shareholding
21st Jun 20235:33 pmRNSTransaction in Own Shares
20th Jun 20235:47 pmRNSTransaction in Own Shares
19th Jun 20235:34 pmRNSTransaction in Own Shares
16th Jun 20235:45 pmRNSTransaction in Own Shares
15th Jun 20235:38 pmRNSTransaction in Own Shares
14th Jun 20235:21 pmRNSTransaction in Own Shares
13th Jun 20235:45 pmRNSTransaction in Own Shares
13th Jun 20231:00 pmRNSDirector/PDMR Shareholding
12th Jun 20235:46 pmRNSTransaction in Own Shares
9th Jun 20235:41 pmRNSTransaction in Own Shares
8th Jun 20235:48 pmRNSTransaction in Own Shares
7th Jun 20235:43 pmRNSTransaction in Own Shares
6th Jun 20235:32 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.